Literature DB >> 22209615

Endothelium-dependent nitric oxide and hyperpolarization-mediated venous relaxation pathways in rat inferior vena cava.

Joseph D Raffetto1, Peng Yu, Ossama M Reslan, Yin Xia, Raouf A Khalil.   

Abstract

INTRODUCTION: The vascular endothelium plays a major role in the control of arterial tone; however, its role in venous tissues is less clear. The purpose of this study was to determine the role of endothelium in the control of venous function and the relaxation pathways involved.
METHODS: Circular segments of inferior vena cava (IVC) from male Sprague-Dawley rats were suspended between two wires and isometric contraction to phenylephrine (Phe; 10(-5)M) and 96 mM KCl was measured. Acetylcholine (Ach; 10(-10) to 10(-5)M) was added and the percentage of venous relaxation was measured. To determine the role of nitric oxide (NO) and prostacyclin (PGI(2)), vein relaxation was measured in the presence of the nitric oxide synthase inhibitor N(ω)-nitro-L-arginine methyl ester (L-NAME; 3 × 10(-4) M) and the cyclooxygenase inhibitor indomethacin (10(-5) M). To measure the role of hyperpolarization, vein relaxation was measured in the presence of K(+) channel activator cromakalim (10(-11) to 10(-6) M), and the nonselective K(+) channel blocker tetraethylammonium (TEA; 10(-3) M). To test for the contribution of a specific K(+) channel, the effects of K(+) channel blockers: glibenclamide (adenosine triphosphate [ATP]-sensitive K(ATP), 10(-5) M), 4-aminopyridine (4-AP; voltage-dependent K(v), 10(-3) M), apamin (small conductance Ca(2+)-dependent SK(Ca), 10(-7) M), and iberiotoxin (large conductance Ca(2+)-dependent BK(Ca), 10(-8) M) on Ach-induced relaxation were tested.
RESULTS: Ach caused concentration-dependent relaxation of Phe contraction (maximum 49.9 ± 4.9%). Removal of endothelium abolished Ach-induced relaxation. IVC treatment with L-NAME partially reduced Ach relaxation (32.8 ± 4.9%). In IVC treated with L-NAME plus indomethacin, significant Ach-induced relaxation (33.6 ± 3.2%) could still be observed, suggesting a role of endothelium-derived hyperpolarizing factor (EDHF). In IVC treated with L-NAME, indomethacin and TEA, Ach relaxation was abolished, supporting a role of EDHF. In veins stimulated with high KCl, Ach caused relaxation (maximum 59.5 ± 3.5%) that was abolished in the presence of L-NAME and indomethacin suggesting that any Ach-induced EDHF is blocked in the presence of high KCl depolarizing solution, which does not favor outward movement of K(+) ion and membrane hyperpolarization. Cromakalim, an activator of K(ATP), caused significant IVC relaxation when applied alone or on top of maximal Ach-induced relaxation, suggesting that the Ach response may not involve K(ATP). Ach-induced relaxation was not inhibited by glibenclamide, 4-AP, or apamin, suggesting little role of K(ATP), K(v) or SK(Ca), respectively. In contrast, iberiotoxin significantly inhibited Ach-induced relaxation, suggesting a role of BK(Ca).
CONCLUSIONS: Thus, endothelium-dependent venous relaxation plays a major role in the control of venous function. In addition to NO, an EDHF pathway involving BK(Ca) may play a role in endothelium-dependent venous relaxation.
Copyright © 2012 Society for Vascular Surgery. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209615      PMCID: PMC3320697          DOI: 10.1016/j.jvs.2011.10.124

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  56 in total

1.  [Primary varicose veins--changes in the venous wall and elastic behavior].

Authors:  D Kirsch; W Wahl; T Böttger; T Junginger
Journal:  Chirurg       Date:  2000-03       Impact factor: 0.955

2.  Changes in the extracellular matrix of the vein wall--the cause of primary varicosis?

Authors:  D Kirsch; H P Dienes; R Küchle; H Duschner; W Wahl; T Böttger; T Junginger
Journal:  Vasa       Date:  2000-08       Impact factor: 1.961

Review 3.  Chronic venous disease.

Authors:  John J Bergan; Geert W Schmid-Schönbein; Philip D Coleridge Smith; Andrew N Nicolaides; Michel R Boisseau; Bo Eklof
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

4.  Augmented endothelium-derived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats.

Authors:  Yi Shi; David D Ku; Ricky Y K Man; Paul M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  2006-03-24       Impact factor: 4.030

5.  Prostacyclin-induced relaxations of small porcine pulmonary arteries are enhanced by the basal release of endothelium-derived nitric oxide through an effect on cyclic GMP-inhibited-cyclic AMP phosphodiesterase.

Authors:  T M Zellers; Y Q Wu; J McCormick; P M Vanhoutte
Journal:  Acta Pharmacol Sin       Date:  2000-02       Impact factor: 6.150

6.  A role for heterocellular coupling and EETs in dilation of rat cremaster arteries.

Authors:  Iain N McSherry; Shaun L Sandow; William B Campbell; John R Falck; Michael A Hill; Kim A Dora
Journal:  Microcirculation       Date:  2006-03       Impact factor: 2.628

7.  Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation.

Authors:  Joseph D Raffetto; Reagan L Ross; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2007-02       Impact factor: 4.268

Review 8.  Endothelium-derived epoxyeicosatrienoic acids and vascular function.

Authors:  Ingrid Fleming; Rudi Busse
Journal:  Hypertension       Date:  2006-02-20       Impact factor: 10.190

Review 9.  Endothelium-derived hyperpolarizing factor: where are we now?

Authors:  Michel Félétou; Paul M Vanhoutte
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-16       Impact factor: 8.311

10.  Endothelium-independent relaxation by adrenomedullin in pregnant rat mesenteric artery: role of cAMP-dependent protein kinase A and calcium-activated potassium channels.

Authors:  Gracious R Ross; Chandra Yallampalli
Journal:  J Pharmacol Exp Ther       Date:  2006-03-21       Impact factor: 4.030

View more
  3 in total

Review 1.  Channelopathy of small- and intermediate-conductance Ca2+-activated K+ channels.

Authors:  Young-Woo Nam; Myles Downey; Mohammad Asikur Rahman; Meng Cui; Miao Zhang
Journal:  Acta Pharmacol Sin       Date:  2022-06-17       Impact factor: 7.169

Review 2.  Adenosine-associated delivery systems.

Authors:  Mehdi Kazemzadeh-Narbat; Nasim Annabi; Ali Tamayol; Rahmi Oklu; Amyl Ghanem; Ali Khademhosseini
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121

3.  Sulodexide Improves Contraction and Decreases Matrix Metalloproteinase-2 and -9 in Veins Under Prolonged Stretch.

Authors:  Joseph D Raffetto; Wentao Yu; Xi Wang; Fiorella Calanni; Paolo Mattana; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2020-03       Impact factor: 3.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.